These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9376156)

  • 1. [A study of the incidence and hospital follow-up of epistaxis in patients treated with anticoagulant acenocoumarol].
    García Callejo FJ; Velert Vila MM; Orts Alborch MH; Monzó Gandía R; Pardo Mateu L; Rubio Escolano F; Marco Algarra J
    Acta Otorrinolaringol Esp; 1997; 48(5):358-62. PubMed ID: 9376156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistaxis and dabigatran, a new non-vitamin K antagonist oral anticoagulant.
    García Callejo FJ; Bécares Martínez C; Calvo González J; Martínez Beneyto P; Marco Sanz M; Marco Algarra J
    Acta Otorrinolaringol Esp; 2014; 65(6):346-54. PubMed ID: 24958185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epistaxis and anticoagulation - a medical and economic challenge?].
    Bermüller C; Bender M; Brögger C; Petereit F; Schulz M
    Laryngorhinootologie; 2014 Apr; 93(4):249-55. PubMed ID: 24135824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulation.
    Tàssies D; Freire C; Pijoan J; Maragall S; Monteagudo J; Ordinas A; Reverter JC
    Haematologica; 2002 Nov; 87(11):1185-91. PubMed ID: 12414349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemorrhagic incidents during prolonged ambulatory treatment with acenocoumarol].
    Reverter JC; Tàssies D; Maragall S; Monteagudo J; Escolar G; Ordinas A
    Med Clin (Barc); 1995 Jun; 105(4):127-30. PubMed ID: 7623503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].
    Katona A; Márk L
    Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epistaxis in anticoagulated patients: Fewer hospital admissions and shorter hospital stays on rivaroxaban compared to phenprocoumon.
    Sauter TC; Hegazy K; Hautz WE; Krummrey G; Ricklin ME; Nagler M; Borner U; Exadaktylos AK
    Clin Otolaryngol; 2018 Feb; 43(1):103-108. PubMed ID: 28510336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiological notes on nasal bleeding].
    Vaamonde Lago P; Martín Martín C; Lechuga García MR; Mínguez Beltrán I; Labella Caballero T
    An Otorrinolaringol Ibero Am; 2004; 31(2):123-32. PubMed ID: 15185608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracranial hemorrhage in patients undergoing anticoagulant treatment with acenocoumarol].
    Elcano J; Martínez JM; Foncuberta J; Grau E; Félez J; Ruscalleda J
    Med Clin (Barc); 1990 Feb; 94(6):201-3. PubMed ID: 2329852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparin (nadroparine) versus oral anticoagulant (acenocoumarol) in the long-term treatment of deep venous thrombosis: comparison of efficacy, safety and hospitalisation period in 105 patients.
    Mazokopakis EE; Vrentzos GE; Ganotakis ES
    Curr Med Res Opin; 2003; 19(6):565-6. PubMed ID: 14594529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of cytochrome P450 2C9 genotype for the bleeding complications in patients treated with acenocoumarol].
    Márk L; Márki-Zay J; Fodor L; Kondacs A; Paragh G; Katona A
    Orv Hetil; 2005 Apr; 146(16):739-43. PubMed ID: 15889670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
    Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
    Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epistaxis: prospective study on emergency care at the hospital level].
    Vaamonde Lago P; Lechuga García MR; Mínguez Beltrán I; Frade González C; Soto Varela A; Bartual Magro J; Labella Caballero T
    Acta Otorrinolaringol Esp; 2000; 51(8):697-702. PubMed ID: 11270104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epistaxis: are temperature and seasonal variations true factors in incidence?
    Bray D; Giddings CE; Monnery P; Eze N; Lo S; Toma AG
    J Laryngol Otol; 2005 Sep; 119(9):724-6. PubMed ID: 16156915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epistaxis and oral anticoagulant therapy.
    Choudhury N; Sharp HR; Mir N; Salama NY
    Rhinology; 2004 Jun; 42(2):92-7. PubMed ID: 15224636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
    Pérez-Gómez F; Alegría E; Berjón J; Iriarte JA; Zumalde J; Salvador A; Mataix L;
    J Am Coll Cardiol; 2004 Oct; 44(8):1557-66. PubMed ID: 15489085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
    Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laryngeal dyspnea in relation to an interaction between acenocoumarol and topical econazole lotion.
    Wey PF; Petitjeans F; Lions C; Ould-Ahmed M; Escarment J
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):173-7. PubMed ID: 18775393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.